Is STERIS plc (STE) overvalued? · P/E 25, rev $5.46B
STERIS plc (STE) is a medical devices company listed on NYSE.
This page asks whether STERIS plc (STE) looks expensive on cached numbers — not a short thesis.
Latest reported STE revenue for 2025-03-31 was $5.46B. Net income was $616.1M. Revenue was up 284.6% from 2024-03-31 to 2025-03-31. STE currently screens at market cap $19.43B and trailing P/E 25.1.
STE currently screens at market cap $19.43B and trailing P/E 25.1. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next STE 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the STE stock page for the full model, not this heading.
Not investment advice.